Metraipolis › archive › dc_80a6bc79368e

A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation — Europe PMC PMID:41754196

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754196
DOI
10.3390/nu18040679
License (as archived)
solo-consultazione
Archived
2026-11-05T15:45:32.634Z
SHA-256 of the archived text
930828a89d6746bccf690ef07b853ff77f7125a95d6b32a9ece5a773788526a2
Stable URL of this page
https://metraipolis.com/documento/dc_80a6bc79368e

How to cite

A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation — Europe PMC PMID:41754196 — Europe PMC (en), https://europepmc.org/article/MED/41754196 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80a6bc79368e (Metraipolis archive dc_80a6bc79368e, sha256 930828a89d6746bccf690ef07b853ff77f7125a95d6b32a9ece5a773788526a2)
BibTeX
@misc{dc80a6bc79368e,
  title = {A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation — Europe PMC PMID:41754196},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754196},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80a6bc79368e; sha256 930828a89d6746bccf690ef07b853ff77f7125a95d6b32a9ece5a773788526a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754196. Agents can read the archived copy with the MCP tool read_document.